Inventor · disambiguated record
Daniel Mark Corey
Also filed as: COREY DANIEL MARK
5 granted patents·14 pending applications·9 citations·filing 2016–2025
71Inventor score
Files withCERO THERAPEUTICS INC11CERO THERAPEUTICS HOLDINGS INC5UNIV LELAND STANFORD JUNIOR2CERO THERPEUTICS HOLDINGS INC1
Top patents by PatentIndex Score
19 records- 0189US11655282B2Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2021·Granted May 23, 2023·5 cites·12 claims
- 0283US11708423B2Chimeric engulfment receptor molecules and methods of useCERO THERAPEUTICS INC·Filed 2018·Granted Jul 25, 2023·3 cites·27 claims
- 0372US12291557B2Chimeric TIM4 receptors and uses thereofCERO THERAPEUTICS HOLDINGS INC·Filed 2019·Granted May 6, 2025·1 cites·11 claims
- 0472US2024368244A1Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0566US2024174766A1Chimeric engulfment receptor molecules and methods of useCERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0663US2024285684A1Anti-cd72 chimeric receptors and uses thereofCERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0758US2024285682A1Chimeric tim receptors and uses thereofCERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0855US12303551B2Cellular immunotherapy compositions and uses thereofCERO THERPEUTICS HOLDINGS INC·Filed 2019·Granted May 20, 2025·0 cites·26 claims
- 0954US2025250315A1Chimeric tim4 receptors and uses thereofCERO THERAPEUTICS HOLDINGS INC·Filed 2025·Application pending·0 cites
- 1053US2025127896A1Chimeric tim4 receptors and uses thereofCERO THERAPEUTICS HOLDINGS INC·Filed 2022·Application pending·0 cites
- 1151US2020055917A1Chimeric engulfment receptor moleculesCERO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1248US2025195575A1Chimeric tim receptors and uses thereofCERO THERAPEUTICS HOLDINGS INC·Filed 2025·Application pending·0 cites
- 1347US2021253696A1Bivalent chimeric engulfment receptors and uses thereofCERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1446US10934331B2Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cellsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Mar 2, 2021·0 cites·11 claims
- 1546US2024058446A1Chimeric tim4 receptors and uses thereofCERO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1645US2021024607A1Expression vectors for chimeric engulfment receptors, genetically modified host cells, and uses thereofCERO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1745US2021015865A1Chimeric engulfment receptors and uses thereof for neurodegenerative diseasesCERO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1845US2025186491A1Compositions and methods for treating cancer with chimeric tim receptors in combination with inhibitors of poly (adp-ribose) polymeraseCERO THERAPEUTICS HOLDINGS INC·Filed 2021·Application pending·0 cites
- 1936US2018147257A1Btn3a ectodomain proteins and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Mark Corey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →